Tag: major depression

A novel antidepressant (AXS-05, Axsome Therapeutics) appears to have a rapid and durable effect in patients with major depressive disorder (MDD), results of an open label, phase 3 trial, show. Yet, its new drug application (NDA) remains in limbo with the US Food and Drug Administration (FDA) for reasons that are unclear. In the study,

Young adults who use cannabis ― either sporadically, daily, or those who have cannabis use disorder ― have a significantly increased risk for suicidal thoughts and actions, according to US national drug survey data. The risks appear greater for women than men and remained regardless of whether the individual was depressed. “We cannot establish that